Clinical Trial Update: A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Brenipatide for Bipolar Disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Brenipatide

Snippet

Sponsor: Eli Lilly and Company | Conditions: Bipolar Disorder | Phase 2 | Status: RECRUITING